[ct-Mode of Action in the Teratogenic Experiment]
- PMID: 125003
- DOI: 10.1007/BF00284400
[ct-Mode of Action in the Teratogenic Experiment]
Abstract
The doses of 10 and 20 mg/kg N-methyl-N-nitrosourea which were teratogenetically effective after a single dose were distributed over 12,24, 48, and 96 hrs during the embryonic developmental phase of the rat. It turned out that the effects were enormously increased when both doses were given in ten single doses during 12 hrs. The number of fetuses that had died down during gestation was increased considerably, the surviving fetuses bore, without exception, the marks of extreme malformations, as, for example, big haemorrhagic cysts instead of the mandible and the tongue. The distribution of the doses over 24 hrs showed, as far as quantity is concerned, comparable teratogenic effects, which, however, during the time of treatment varied in quality according to the variation of the critical sensitivity of the developmental phase. The distribution over even longer periods of time gradually weakened the effect. There were also some other symptoms that became manifest. So it can be said that N-methyl-N-nitrosourea is according to its teratogenic effects also a typical ct-poison (Druckrey) with the maximum of cumulation after distributing the dose over 12 hrs of the gestation.
Similar articles
-
[Teratogenic action of ethyl-nitrosourea in Göttingen miniature pigs (author's transl)].Arzneimittelforschung. 1975 Oct;25(10):1606-8. Arzneimittelforschung. 1975. PMID: 1243047 German.
-
[Teratogenic effect of N-methyl-N-nitrosourea on the brain anlage of rat embryos using autoradiographic methods (author's transl)].Pathol Res Pract. 1978 Sep;163(1):1-8. Pathol Res Pract. 1978. PMID: 704481 German. No abstract available.
-
Reproduction and teratological studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the rat and rabbit.Toxicol Appl Pharmacol. 1975 Dec;34(3):456-66. doi: 10.1016/0041-008x(75)90139-8. Toxicol Appl Pharmacol. 1975. PMID: 1209639 No abstract available.
-
Clinical teratology: identifying teratogenic risks in humans.Clin Genet. 1999 Dec;56(6):409-20. doi: 10.1034/j.1399-0004.1999.560601.x. Clin Genet. 1999. PMID: 10665659 Review. No abstract available.
-
Retinoids as teratogens.Annu Rev Nutr. 1995;15:111-32. doi: 10.1146/annurev.nu.15.070195.000551. Annu Rev Nutr. 1995. PMID: 8527214 Review.
References
-
- Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1965 Nov 18;252(2):196-204 - PubMed
-
- Arzneimittelforschung. 1971 Jan;21(1):13-5 - PubMed
-
- Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1975;83(1):31-55 - PubMed
-
- Arzneimittelforschung. 1969 Jul;19(7):1091-3 - PubMed
-
- Arzneimittelforschung. 1970 Mar;20(3):418-9 - PubMed